A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder
Trial details
- Registry ID
- NCT06126653
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate ARD-501 in Patients With Autism Spectrum DisorderNCT06126653 | AARD | Phase 2 | Completed | 2025-01-13Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |